192 results
Page 4 of 10
PRER14A
fw0at6vycs2 o2bbu
6 Oct 23
Preliminary revised proxy
9:40pm
8-K
EX-10.1
hrud0d
5 Sep 23
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones
7:06am
8-K
EX-99.1
gwwi40ytvyseu7ij
5 Sep 23
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones
7:06am
8-K
EX-99.1
ud4ic zbwy
11 Aug 23
Aeglea BioTherapeutics Reports Second Quarter 2023 Financial Results
7:02am
8-K
EX-99.1
8rcm2mwkosxc5lcf
27 Jul 23
Aeglea BioTherapeutics Announces Sale of Pegzilarginase to Immedica Pharma
7:01am
8-K
EX-2.1
bc7ekd1
23 Jun 23
Entry into a Material Definitive Agreement
9:16am
8-K
EX-3.1
3jfb778r 7j
23 Jun 23
Entry into a Material Definitive Agreement
9:16am
8-K
EX-10.1
7bu9apy8sdn64oj7oucj
23 Jun 23
Entry into a Material Definitive Agreement
9:16am
8-K
w7o4jbrxy32py5z
23 Jun 23
Entry into a Material Definitive Agreement
9:16am
8-K
EX-99.1
qwzui0 esigdrceo1pnz
22 Jun 23
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
5:20pm
8-K
oohucrz
22 Jun 23
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
5:20pm